NIAGEN BIOSCIENCE, INC. Fees and Commissions, Fiduciary and Trust Activities (Deprecated 2018-01-31)
NIAGEN BIOSCIENCE, INC. (NAGE) reported Fees and Commissions, Fiduciary and Trust Activities (Deprecated 2018-01-31) of $20.00 thousand for the 12-month period ending 2013-12-28, per its 10-K filed 2016-03-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FeesAndCommissionsFiduciaryAndTrustActivities · last filed 2016-03-17
- NIAGEN BIOSCIENCE, INC. fees and commissions, fiduciary and trust activities (deprecated 2018-01-31) for fiscal 2013 was $20.00K.
| Period end | Fees and Commissions, Fiduciary and Trust Activities (Deprecated 2018-01-31) 12 month |
|---|---|
| 2013-12-28 | $20.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |